initial public offerings (IPOs) trading on American exchanges

Wednesday, September 3, 2014

Iradimed (IRMD) began trading on the NASDAQ on 16 July 2014


iRadimed Corporation is a provider of non-magnetic intravenous (IV) infusion pump systems that are safe for use during magnetic resonance imaging (MRI) procedures. Electromechanical medical devices and pumps contain magnetic and electronic parts which generate radio frequency (RF) noise, create interference and are dangerous to operate in the presence of the smagnet which drives an MRI. Its mRidium (3850/3860+) IV pump systems have been designed with non-ferrous parts, ceramic ultrasonic motors, non-magnetic mobile stand and other special features in order to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures. The Company’s pump solution provides a seamless approach to providing IV fluids before, during and after an MRI scan. As of March 31, 2014, it has approximately 1,917 IV infusion pump systems installed globally.


7457 Aloma Ave, SUITE 201
WINTER PARK, FL 32792-9172
United States

Key stats and ratios

Q1 (Mar '14)2013
Net profit margin14.71%17.08%
Operating margin23.17%24.58%
EBITD margin-25.80%
Return on average assets28.47%30.89%
Return on average equity36.40%44.82%

No comments:

Post a Comment